Add bone density markers (calcium, vitamin D, alkaline phosphatase) because rapid weight loss in older adults accelerates bone density loss
Beyond producing accurate results, we transform biochemical data into meaningful diagnostic evidence, enabling earlier recognition of metabolic syndrome and supporting timely clinical intervention
Tirzepatide has shown significant promise as a weight loss medication, helping individuals regulate appetite and achieve sustainable weight management
[3] Healthcare providers should assess nutritional status based on individual risk factors and monitor for potential deficiencies, particularly in patients experiencing significant weight loss or persistent gastrointestinal symptoms
Eli Lilly, the manufacturer of branded tirzepatide, has now released testing data showing significant impurities in compounded tirzepatide-B12 products, and the findings raise questions that every single person using these formulations needs to understand
